2022 annual financial data
Radiopharm Theranostics 2022 Operating margin
Direct answer
Operating margin was -225,527.71%.
Operating income was -19,916,352 AUD and net income was -30,338,979 AUD.
Operating cash flow was -9,915,654 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,831 AUD
- Operating income
- -19,916,352 AUD
- Net income
- -30,338,979 AUD
- Operating cash flow
- -9,915,654 AUD